Suggested Topics within your search.
Suggested Topics within your search.
- Antiviral Agents
- COVID-19 12
- COVID-19 (Disease) 12
- SARS-CoV-2 12
- Treatment 12
- Antiviral agents 10
- Chemotherapy 10
- Coronavirus infections 10
- Development 10
- drug therapy 10
- therapeutic use 8
- Clinical trials 6
- Research 6
- administration & dosage 6
- Antibodies, Monoclonal 4
- Betacoronavirus 4
- Clinical Trials as Topic 4
- Coronavirus Infections 4
- Drug Discovery 4
- Drug development 4
- Immunological aspects 4
- Interferon 4
- Interferon-beta 4
- Monoclonal antibodies 4
- Nebulizers and Vaporizers 4
- Pneumonia, Viral 4
- Therapeutic use 4
- Treatment Outcome 4
- drug effects 4
- immunology 4
-
1
-
2
-
3
INFbeta therapy for COVID-19 the new SNG001 drug /
Published 2020Subjects: Get full text
Series
Electronic Audio -
4
INFbeta therapy for COVID-19 the new SNG001 drug /
Published 2020Subjects: Get full text
Series
Electronic Audio -
5
SARS-CoV-2 human monoclonal antibody therapy
Published 2020Subjects: Get full text
Series
Electronic Audio -
6
SARS-CoV-2 human monoclonal antibody therapy
Published 2020Subjects: Get full text
Series
Electronic Audio -
7
SARS-COV-2 human monoclonal antibody therapy update
Published 2021Subjects: Get full text
Series
Electronic Audio -
8
SARS-COV-2 human monoclonal antibody therapy update
Published 2021Subjects: Get full text
Series
Electronic Audio -
9
The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells
Published 2021Subjects: Get full text
Series
Electronic Audio -
10
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Subjects: Get full text
Series
Electronic Audio -
11
Update on the SNG001 drug, an INFbeta therapy for COVID-19
Published 2020Subjects: Get full text
Series
Electronic Audio -
12
The role of short linear motifs (SLiMs) in SARS-CoV-2 entry into human cells
Published 2021Subjects: Get full text
Series
Electronic Audio